The DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
Self-citationCrystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
Brejc, K., van Dijk, W. J., Klaassen, R. V., Schuurmans, M., van der Oost, J., Smit, A. B., & Sixma, T. K. (2001) · Nature · doi:10.1038/35077011 · Cited by 1,759
Refined Structure of the Nicotinic Acetylcholine Receptor at 4Å Resolution
Unwin, N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.12.031 · Cited by 1,659
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523
A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate
Katz, B., & Thesleff, S. (1957) · The Journal of Physiology · doi:10.1113/jphysiol.1957.sp005838 · Cited by 1,461
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationAmos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275
Structure and gating mechanism of the acetylcholine receptor pore
Miyazawa, A., Fujiyoshi, Y., & Unwin, N. (2003) · Nature · doi:10.1038/nature01748 · Cited by 1,270
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Recognition Dynamics Up to Microseconds Revealed from an RDC-Derived Ubiquitin Ensemble in Solution
Lange, O. F., Lakomek, N.-A., Farès, C., Schröder, G. F., Walter, K. F. A., Becker, S., Meiler, J., Grubmüller, H., Griesinger, C., & de Groot, B. L. (2008) · Science · doi:10.1126/science.1157092 · Cited by 1,044
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Adair, G. S., Bock, A. V., & Field, H. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)85018-9 · Cited by 823
Nicotinic Receptors at the Amino Acid Level
Corringer, P.-J., Novère, N. L., & Changeux, J.-P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 820
Self-citationRings of negatively charged amino acids determine the acetylcholine receptor channel conductance
Imoto, K., Busch, C., Sakmann, B., Mishina, M., Konno, T., Nakai, J., Bujo, H., Mori, Y., Fukuda, K., & Numa, S. (1988) · Nature · doi:10.1038/335645a0 · Cited by 794
Celie, P. H. N., van Rossum-Fikkert, S. E., van Dijk, W. J., Brejc, K., Smit, A. B., & Sixma, T. K. (2004) · Neuron · doi:10.1016/s0896-6273(04)00115-1 · Cited by 781
Allosteric Mechanisms of Signal Transduction
Changeux, J.-P., & Edelstein, S. J. (2005) · Science · doi:10.1126/science.1108595 · Cited by 747
Self-citationCoarse-grained normal mode analysis in structural biology
Bahar, I., & Rader, A. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.08.007 · Cited by 731
Role of dopamine in the behavioural actions of nicotine related to addiction
Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 681
Allostery and cooperativity revisited
Cui, Q., & Karplus, M. (2008) · Protein Science · doi:10.1110/ps.03259908 · Cited by 681
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation
Bocquet, N., Nury, H., Baaden, M., Le Poupon, C., Changeux, J.-P., Delarue, M., & Corringer, P.-J. (2009) · Nature · doi:10.1038/nature07462 · Cited by 674
Self-citationSAHAKIAN, B. J., MORRIS, R. G., EVENDEN, J. L., HEALD, A., LEVY, R., PHILPOT, M., & ROBBINS, T. W. (1988) · Brain · doi:10.1093/brain/111.3.695 · Cited by 666
X-ray structure of a prokaryotic pentameric ligand-gated ion channel
Hilf, R. J. C., & Dutzler, R. (2008) · Nature · doi:10.1038/nature06717 · Cited by 665
Hansen, S. B., Sulzenbacher, G., Huxford, T., Marchot, P., Taylor, P., & Bourne, Y. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600828 · Cited by 641
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566
Zhong, W., Gallivan, J. P., Zhang, Y., Li, L., Lester, H. A., & Dougherty, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12088 · Cited by 550
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Arroyo-Jimenez, M. D. M., Cordero-Erausquin, M., Léna, C., Novère, N. L., d'Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J.-P. (1999) · Nature · doi:10.1038/19756 · Cited by 542
Self-citationProof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 527
Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel
Hilf, R. J. C., & Dutzler, R. (2009) · Nature · doi:10.1038/nature07461 · Cited by 526
Recent advances in Cys-loop receptor structure and function
Sine, S. M., & Engel, A. G. (2006) · Nature · doi:10.1038/nature04708 · Cited by 521
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422
Galzi, J.-L., Devillers-Thiery, A., Hussy, N., Bertrand, S., Changeux, J.-P., & Bertrand, D. (1992) · Nature · doi:10.1038/359500a0 · Cited by 418
Self-citationKihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 415
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412
Le Novère, N., Corringer, P., & Changeux, J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10153 · Cited by 411
Self-citationThe cholinergic system in Alzheimer's disease
Kása, P., Rakonczay, Z., & Gulya, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00028-2 · Cited by 409
Dellisanti, C. D., Yao, Y., Stroud, J. C., Wang, Z.-Z., & Chen, L. (2007) · Nature Neuroscience · doi:10.1038/nn1942 · Cited by 407
Rollema, H., Coe, J. W., Chambers, L. K., Hurst, R. S., Stahl, S. M., & Williams, K. E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.003 · Cited by 400
Bertrand, D., Galzi, J. L., Devillers-Thiéry, A., Bertrand, S., & Changeux, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6971 · Cited by 391
Self-citationTobi, D., & Bahar, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507603102 · Cited by 379
Bannon, A. W., Decker, M. W., Holladay, M. W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P. S., Bitner, R. S., Diaz, A., Dickenson, A. H., Porsolt, R. D., et al. (1998) · Science · doi:10.1126/science.279.5347.77 · Cited by 368
Cognitive function in schizophrenia
Sharma, T., & Antonova, L. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00084-9 · Cited by 367
Nicotine binding to brain receptors requires a strong cation–π interaction
Xiu, X., Puskar, N. L., Shanata, J. A. P., Lester, H. A., & Dougherty, D. A. (2009) · Nature · doi:10.1038/nature07768 · Cited by 363
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361
Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?
Schuller, H. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2590 · Cited by 355
Champtiaux, N., Han, Z.-Y., Bessis, A., Rossi, F. M., Zoli, M., Marubio, L., McIntosh, J. M., & Changeux, J.-P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345
Self-citationOn the nature of allosteric transitions: Implications of non-exclusive ligand binding
Rubin, M. M., & Changeux, J.-P. (1966) · Journal of Molecular Biology · doi:10.1016/0022-2836(66)90097-0 · Cited by 339
Self-citationOn the nature of partial agonism in the nicotinic receptor superfamily
Lape, R., Colquhoun, D., & Sivilotti, L. G. (2008) · Nature · doi:10.1038/nature07139 · Cited by 337
Muscle and neuronal nicotinic acetylcholine receptors: Structure, function and pathogenicity
Kalamida, D., Poulas, K., Avramopoulou, V., Fostieri, E., Lagoumintzis, G., Lazaridis, K., Sideri, A., Zouridakis, M., & Tzartos, S. J. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05935.x · Cited by 333
Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity
Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., & Akaike, A. (1997) · Annals of Neurology · doi:10.1002/ana.410420205 · Cited by 321
Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 320
Dennis, M., Giraudat, J., Kotzyba-Hibert, F., Goeldner, M., Hirth, C., Chang, J. Y., Lazure, C., Chretien, M., & Changeux, J. P. (1988) · Biochemistry · doi:10.1021/bi00407a016 · Cited by 317
Self-citationHucho, F., Oberthür, W., & Lottspeich, F. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80881-x · Cited by 316
Bourne, Y., Talley, T. T., Hansen, S. B., Taylor, P., & Marchot, P. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600620 · Cited by 316
Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312
Self-citationA prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family
Bocquet, N., Prado de Carvalho, L., Cartaud, J., Neyton, J., Le Poupon, C., Taly, A., Grutter, T., Changeux, J.-P., & Corringer, P.-J. (2007) · Nature · doi:10.1038/nature05371 · Cited by 312
Self-citationSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310
Celie, P. H. N., Kasheverov, I. E., Mordvintsev, D. Y., Hogg, R. C., van Nierop, P., van Elk, R., van Rossum-Fikkert, S. E., Zhmak, M. N., Bertrand, D., Tsetlin, V., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb951 · Cited by 310
Intravenous nicotine in Alzheimer's disease: a pilot study
Newhouse, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
Lefkowitz, R. J., Rajagopal, K., & Whalen, E. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.007 · Cited by 301
Giraudat, J., Dennis, M., Heidmann, T., Chang, J. Y., & Changeux, J. P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2719 · Cited by 301
Self-citationNovel pharmacological targets for the treatment of Parkinson's disease
Schapira, A. H. V., Bezard, E., Brotchie, J., Calon, F., Collingridge, G. L., Ferger, B., Hengerer, B., Hirsch, E., Jenner, P., Novère, N. L., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2087 · Cited by 298
Hierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors
Mameli-Engvall, M., Evrard, A., Pons, S., Maskos, U., Svensson, T. H., Changeux, J.-P., & Faure, P. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.007 · Cited by 296
Self-citationNicotinic receptor function: new perspectives from knockout mice
Cordero-Erausquin, M., Marubio, L. M., Klink, R., & Changeux, J.-P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01489-9 · Cited by 295
Self-citationβ-Amyloid1–42Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice
Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 290
Li, G.-D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., & Cohen, J. B. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-06.2006 · Cited by 289
Guan, Z., Zhang, X., Ravid, R., & Nordberg, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740237.x · Cited by 285
Flynn, D. D., & Mash, D. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13113.x · Cited by 285
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Selective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 281
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Le Novère, N., Grutter, T., & Changeux, J.-P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042699699 · Cited by 263
Self-citationNicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261
Self-citationPotentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site
Young, G. T., Zwart, R., Walker, A. S., Sher, E., & Millar, N. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804372105 · Cited by 261
Krebs, W. G., Alexandrov, V., Wilson, C. A., Echols, N., Yu, H., & Gerstein, M. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10168 · Cited by 256
Allosteric modulation of nicotinic acetylcholine receptors
Bertrand, D., & Gopalakrishnan, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.011 · Cited by 255
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
Galzi, J. L., Revah, F., Black, D., Goeldner, M., Hirth, C., & Changeux, J. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86964-2 · Cited by 249
Self-citationUnwin, N., Miyazawa, A., Li, J., & Fujiyoshi, Y. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00381-9 · Cited by 246
Tasneem, A., Iyer, L. M., Jakobsson, E., & Aravind, L. (2004) · Genome Biology · doi:10.1186/gb-2004-6-1-r4 · Cited by 244
Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242
Kitagawa, H., Takenouchi, T., Azuma, R., Wesnes, K. A., Kramer, W. G., Clody, D. E., & Burnett, A. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300028 · Cited by 238
Nicotinic receptor abnormalities in Alzheimer’s disease
Court, J., Martin-Ruiz, C., Piggott, M., Spurden, D., Griffiths, M., & Perry, E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01116-1 · Cited by 235
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233
Koshland, D. E. (1963) · Science · doi:10.1126/science.142.3599.1533 · Cited by 233
Blockade of Nicotine Self-Administration with Nicotinic Antagonists in Rats
Watkins, S. S., Epping-Jordan, M. P., Koob, G. F., & Markou, A. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00226-3 · Cited by 233
Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., Soriano, J., Fine, C., Abrams, A., Rater, M., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1931 · Cited by 230
Vincler, M., Wittenauer, S., Parker, R., Ellison, M., Olivera, B. M., & McIntosh, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608715103 · Cited by 227
Salas, R., Pieri, F., & De Biasi, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1939-04.2004 · Cited by 226
Mapping of the Benzodiazepine Recognition Site on GABA-A Receptors
Sigel, E. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393444 · Cited by 225
Grady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222
Cartaud, J., Benedetti, E. L., Cohen, J. B., Meunier, J.-C., & Changeux, J.-P. (1973) · FEBS Letters · doi:10.1016/0014-5793(73)80171-1 · Cited by 220
Self-citationDetection and trapping of intermediate states priming nicotinic receptor channel opening
Mukhtasimova, N., Lee, W. Y., Wang, H.-L., & Sine, S. M. (2009) · Nature · doi:10.1038/nature07923 · Cited by 218
Schizophrenia and the α7 Nicotinic Acetylcholine Receptor
Martin, L. F., & Freedman, R. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78008-4 · Cited by 213
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Arneric, S. P., Holladay, M., & Williams, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.033 · Cited by 208
Jackson, K. J., Martin, B. R., Changeux, J. P., & Damaj, M. I. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132977 · Cited by 208
Self-citationLigand-gated ion channels: mechanisms underlying ion selectivity
Keramidas, A., Moorhouse, A. J., Schofield, P. R., & Barry, P. H. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.09.002 · Cited by 208
Nicotinic receptors in aging and dementia
Picciotto, M. R., & Zoli, M. (2002) · Journal of Neurobiology · doi:10.1002/neu.10102 · Cited by 208
Stevens, K. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00178-g · Cited by 203
Blanton, M. P., & Cohen, J. B. (1994) · Biochemistry · doi:10.1021/bi00176a016 · Cited by 201
Dziewczapolski, G., Glogowski, C. M., Masliah, E., & Heinemann, S. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6159-08.2009 · Cited by 198
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197
Ulens, C., Hogg, R. C., Celie, P. H., Bertrand, D., Tsetlin, V., Smit, A. B., & Sixma, T. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507889103 · Cited by 193
Normal Mode Analysis Suggests a Quaternary Twist Model for the Nicotinic Receptor Gating Mechanism
Taly, A., Delarue, M., Grutter, T., Nilges, M., Le Novère, N., Corringer, P.-J., & Changeux, J.-P. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.050229 · Cited by 189
Self-citationCelie, P. H. N., Klaassen, R. V., van Rossum-Fikkert, S. E., van Elk, R., van Nierop, P., Smit, A. B., & Sixma, T. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414476200 · Cited by 182
Satkunanathan, N., Livett, B., Gayler, K., Sandall, D., Down, J., & Khalil, Z. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.009 · Cited by 180
Galzi, J. L., Bertrand, S., Corringer, P. J., Changeux, J. P., & Bertrand, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00969.x · Cited by 179
Self-citationBurghaus, L., Schütz, U., Krempel, U., de Vos, R. A. I., Jansen Steur, E. N. H., Wevers, A., Lindstrom, J., & Schröder, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00031-0 · Cited by 178
Dépatie, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00372-x · Cited by 175
Structural basis for lipid modulation of nicotinic acetylcholine receptor function
Barrantes, F. J. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.06.008 · Cited by 175
Biton, B., Bergis, O. E., Galli, F., Nedelec, A., Lochead, A. W., Jegham, S., Godet, D., Lanneau, C., Santamaria, R., Chesney, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301189 · Cited by 173
α-RgIA: A Novel Conotoxin That Specifically and Potently Blocks the α9α10 nAChR,
Ellison, M., Haberlandt, C., Gomez-Casati, M. E., Watkins, M., Elgoyhen, A. B., McIntosh, J. M., & Olivera, B. M. (2006) · Biochemistry · doi:10.1021/bi0520129 · Cited by 171
Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery
Gotti, C., Riganti, L., Vailati, S., & Clementi, F. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474486 · Cited by 171
Executive and social behaviors under nicotinic receptor regulation
Granon, S., Faure, P., & Changeux, J.-P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533498100 · Cited by 170
Self-citationMutational Analysis of the Charge Selectivity Filter of the α7 Nicotinic Acetylcholine Receptor
Corringer, P.-J., Bertrand, S., Galzi, J.-L., Devillers-Thiéry, A., Changeux, J.-P., & Bertrand, D. (1999) · Neuron · doi:10.1016/s0896-6273(00)80741-2 · Cited by 166
Self-citationNicotinic receptors in wonderland
Grutter, T., & Changeux, J.-P. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01921-1 · Cited by 165
Self-citationLeiser, S. C., Bowlby, M. R., Comery, T. A., & Dunlop, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.009 · Cited by 165
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · cited 1×
“In this respect, it should be noted that nicotine and smoking-cessation drugs are usually tested under short-term conditions, while it is becoming clear that long-term chronic exposure to nicotine (and possibly to nicotinic drugs in general) could modify the levels of α4β2 versus α7 nAChR”
BackgroundPotter, A., Corwin, J., Lang, J., Piasecki, M., Lenox, R., & Newhouse, P. A. (1999) · Psychopharmacology · doi:10.1007/s002130050897 · Cited by 163
Ihara, M., Okajima, T., Yamashita, A., Oda, T., Hirata, K., Nishiwaki, H., Morimoto, T., Akamatsu, M., Ashikawa, Y., Kuroda, S., et al. (2008) · Invertebrate Neuroscience · doi:10.1007/s10158-008-0069-3 · Cited by 162
Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential
Romanelli, M. N., Gratteri, P., Guandalini, L., Martini, E., Bonaccini, C., & Gualtieri, F. (2007) · ChemMedChem · doi:10.1002/cmdc.200600207 · Cited by 162
The nicotinic receptor ligand binding domain
Sine, S. M. (2002) · Journal of Neurobiology · doi:10.1002/neu.10139 · Cited by 161
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
García‐Colunga, J., AWAD, J., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2041 · Cited by 158
Localization of nAChR subunit mRNAs in the brain of Macaca mulatta
Han, Z., Le Novère, N., Zoli, M., Hill, J. A., Champtiaux, N., & Changeux, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00262.x · Cited by 156
Self-citationMiwa, J. M., Stevens, T. R., King, S. L., Caldarone, B. J., Ibanez-Tallon, I., Xiao, C., Fitzsimonds, R. M., Pavlides, C., Lester, H. A., Picciotto, M. R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.025 · Cited by 154
Acute nicotinic blockade produces cognitive impairment in normal humans
NEWHOUSE, P. A., Potter, A., Corwin, J., & Lenox, R. H. (1992) · Psychopharmacology · doi:10.1007/bf02247425 · Cited by 148
D’Andrea, M. R., & Nagele, R. G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474224 · Cited by 148
Corringer, P., Galzi, J., Eiselé, J.-L., Bertrand, S., Changeux, J., & Bertrand, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.11749 · Cited by 147
Self-citationSteingard, R. J., Yurgelun-Todd, D. A., Hennen, J. A., Moore, J. C., Moore, C. M., Vakili, K., Young, A. D., Katic, A., Beardslee, W. R., & Renshaw, P. F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00942-2 · Cited by 147
Arias, H. R., Bhumireddy, P., & Bouzat, C. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.01.006 · Cited by 147
White, B. H., & Cohen, J. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49602-6 · Cited by 146
Charles, H. C., Lazeyras, F., Krishnan, K. R. R., Boyko, O. B., Payne, M., & Moore, D. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90115-5 · Cited by 145
Desensitization of nicotinic acetylcholine receptors as a strategy for drug development
Buccafusco, J. J., Beach, J. W., & Terry, A. V. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145292 · Cited by 144 · cited 1×
“However, in some cases, desensitization may not only mean the prevention of an excess of ionotropic activit”
BackgroundHauser, T. A., Kucinski, A. J., Green-Jordan, K., Gatto, G. J., Wersinger, S. R., Hesse, R. A., Stachowiak, E. K., Stachowiak, M. K., Papke, R. L., Lippiello, P. M., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.030 · Cited by 143
Jones, S. W. (1999) · The Journal of General Physiology · doi:10.1085/jgp.114.2.271 · Cited by 139
Wilson, G. G., & Karlin, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1241 · Cited by 138
Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function
Fryer, J. D., & Lukas, R. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721117.x · Cited by 138
Age-Related Effects of the Nicotinic Antagonist Mecamylamine on Cognition and Behavior
NEWHOUSE, P. A., Potter, A., Corwin, J., & Lenox, R. H. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.11 · Cited by 137
Blondel, A., Sanger, D. J., & Moser, P. C. (2000) · Psychopharmacology · doi:10.1007/s002130000378 · Cited by 137
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137
Sunderland, T., Tariot, P. N., & NEWHOUSE, P. A. (1988) · Brain Research · doi:10.1016/0006-8993(88)91227-9 · Cited by 135
Livingstone, P. D., Srinivasan, J., Kew, J. N. C., Dawson, L. A., Gotti, C., Moretti, M., Shoaib, M., & Wonnacott, S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06613.x · Cited by 133
The Synthesis, Structural Characterization, and Receptor Specificity of the α-Conotoxin Vc1.1
Clark, R. J., Fischer, H., Nevin, S. T., Adams, D. J., & Craik, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604550200 · Cited by 133
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
Gunthorpe, M. J., & Lummis, S. C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009575200 · Cited by 129
Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129
Stevens, K. E., & Wear, K. D. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00466-2 · Cited by 129
George, T. P., Sacco, K. A., Vessicchio, J. C., Weinberger, A. H., & Shytle, R. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b49e · Cited by 128
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
Quik, M., & Kulak, J. M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00036-0 · Cited by 128
Tropisetron improves deficits in auditory P50 suppression in schizophrenia
Koike, K., Hashimoto, K., Takai, N., Shimizu, E., Komatsu, N., Watanabe, H., Nakazato, M., Okamura, N., Stevens, K. E., Freedman, R., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.016 · Cited by 127
Targeted Molecular Dynamics Study of C-Loop Closure and Channel Gating in Nicotinic Receptors
Cheng, X., Wang, H., Grant, B. J., Sine, S. M., & McCammon, J. A. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020134 · Cited by 126
Bouzat, C., Bartos, M., Corradi, J., & Sine, S. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0448-08.2008 · Cited by 125
Wilens, T. E., Verlinden, M. H., Adler, L. A., Wozniak, P. J., & West, S. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.029 · Cited by 123
Simosky, J. K., Stevens, K. E., Adler, L. E., & Freedman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1285-x · Cited by 121
Experimentally based model of a complex between a snake toxin and the α7 nicotinic receptor
Fruchart‐Gaillard, C., Gilquin, B., Antil-Delbeke, S., Novère, N. G. L., Tamiya, T., Corringer, P., Changeux, J., Ménèz, A., & Servent, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042699899 · Cited by 120
Self-citationLong-term effects of chronic nicotine exposure on brain nicotinic receptors
Besson, M., Granon, S., Mameli-Engvall, M., Cloëz-Tayarani, I., Maubourguet, N., Cormier, A., Cazala, P., David, V., Changeux, J., & Fauré, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702698104 · Cited by 118
Self-citationHansen, S. B., & Taylor, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.067 · Cited by 117
Nicotinic receptors, allosteric proteins and medicine
Changeux, J., & Taly, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.01.001 · Cited by 115
Self-citationA Lipid-dependent Uncoupled Conformation of the Acetylcholine Receptor
daCosta, C. J. B., & Baenziger, J. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900030200 · Cited by 114
Jansen, M., Bali, M., & Akabas, M. H. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200709896 · Cited by 114
Cohen, C., Bergis, O. E., Galli, F., Lochead, A. W., Jegham, S., Biton, B., Léonardon, J., Avenet, P., Sgard, F., Besnard, F., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049262 · Cited by 114
Bitner, R. S., Nikkel, A. L., Curzon, P., Arnerić, S. P., Bannon, A. W., & Decker, M. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05426.1998 · Cited by 113
Franks, F. (1993) · Humana Press eBooks · doi:10.1007/978-1-59259-438-2_2 · Cited by 113
Corringer, P., Bertrand, S., Bohler, S., Edelstein, S. J., Changeux, J., & Bertrand, D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00648.1998 · Cited by 108
Self-citationPopot, J., DEMEL, R. A., Sobel, A., Deenen, L. L. M. V., & Changeux, J. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12209.x · Cited by 108
Self-citationEllison, M., Feng, Z., Park, A. J., Zhang, X., Olivera, B. M., McIntosh, J. M., & Norton, R. S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.082 · Cited by 107
Wehner, J. M., Keller, J. J., Keller, A. B., Picciotto, M. R., Paylor, R. E., Booker, T. K., Beaudet, A. L., Heinemann, S., & Balogh, S. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.016 · Cited by 107
McClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0516-y · Cited by 106
Lin, L., Jeanclos, E. M., Treuil, M. W., Braunewell, K., Gundelfinger, E. D., & Anand, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206857200 · Cited by 105
Bertrand, D., Bertrand, S., Cassar, S. C., Gubbins, E. J., Li, J., & Gopalakrishnan, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042820 · Cited by 104
Donnelly‐Roberts, D. L., Puttfarcken, P. S., Kuntzweiler, T. A., Briggs, C. A., Anderson, D. J., Campbell, J. E., Piattoni-Kaplan, M., McKenna, D. G., Wasicak, J. T., Holladay, M. W., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37422-1 · Cited by 103
Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics
Decker, M. W., & Meyer, M. D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00122-7 · Cited by 103
Han, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Novère, N. G. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 103
Self-citationAndreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101
The nicotinic acetylcholine receptor: From molecular biology to cognition
Changeux, J., Corringer, P., & Maskos, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.024 · Cited by 101
Self-citationFernandes, C., Hoyle, E., Dempster, E. L., Schalkwyk, L. C., & Collier, D. A. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00176.x · Cited by 100
Imaging of Nicotinic and Muscarinic Receptors in Alzheimer's Disease: Effect of Tacrine Treatment
Nordberg, A. K., Lundqvist, H., Hartvig, P., Andersson, J., Johansson, M., Hellström‐Lindahl, E., & Långström, B. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106611 · Cited by 100
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
Taly, A., Corringer, P., Grütter, T., de Carvalho, L. P., Karplus, M., & Changeux, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607477103 · Cited by 99
Self-citationSydserff, S. G., Sutton, E. J., Song, D., Quirk, M. C., Maciag, C. M., Li, Z., Jonak, G. J., Gurley, D. A., Gordon, J. C., Christian, E. P., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.005 · Cited by 98
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 98
Chiara, D. C., Dangott, L. J., Eckenhoff, R. G., & Cohen, J. B. (2003) · Biochemistry · doi:10.1021/bi0351561 · Cited by 97
Integrating smoking cessation treatment into primary care: an effectiveness study
Fiore, M. C., McCarthy, D. E., Jackson, T. C., Zehner, M. E., Jorenby, D. E., Mielke, M. M., Smith, S. S., Guiliani, T. A., & Baker, T. B. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.11.002 · Cited by 97
Hales, T. G., Dunlop, J. I., Deeb, T. Z., Carland, J. E., Kelley, S. P., Lambert, J. J., & Peters, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513222200 · Cited by 95
Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
Faghih, R., Gopalakrishnan, M., & Briggs, C. A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070256g · Cited by 95
Rezvani, A. H., Kholdebarin, E., Brucato, F. H., Callahan, P. M., Lowe, D., & Levin, E. D. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.018 · Cited by 94
Rusted, J. M., NEWHOUSE, P. A., & Levin, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00207-2 · Cited by 91
TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity
Lippiello, P. M., Beaver, J. S., Gatto, G. J., James, J. W., Green-Jordan, K., Traina, V. M., Xie, J., & Bencherif, M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00054.x · Cited by 85
Meyer, E. M., Tay, E. T., Zoltewicz, J. A., Meyers, C., King, M. A., Papke, R. L., & de Fiebre, C. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37338-0 · Cited by 85
Sullivan, J. P., Donnelly‐Roberts, D. L., Briggs, C. A., Anderson, D. J., Gopalakrishnan, M., Xue, I. C., Piattoni-Kaplan, M., Molinari, E. J., Campbell, J. E., McKenna, D. G., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37014-4 · Cited by 82
Tonic nicotinic modulation of serotoninergic transmission in the spinal cord
Cordero‐Erausquin, M., & Changeux, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041600698 · Cited by 81
Self-citation
Cited by
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Resolving postoperative neuroinflammation and cognitive decline
Terrando, N., Eriksson, L. I., Kyu Ryu, J., Yang, T., Monaco, C., Feldmann, M., Jonsson Fagerlund, M., Charo, I. F., Akassoglou, K., & Maze, M. (2011) · Annals of Neurology · doi:10.1002/ana.22664 · Cited by 579
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R., Rollema, H., & Bertrand, D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 522
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
Metadata
- Authors
- Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-09
- Volume
- 8
- Issue
- 9
- Pages
- 733-750
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1992556352
- Cited by
- 703
- References
- 269
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.